ProfileGDS5822 / ILMN_2648523
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 23% 24% 35% 2% 8% 2% 15% 41% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 113.623
GSM1276600PDAC Late Ablation Control 215.924
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 114.835
GSM1276603PDAC Late Ablation 23.22
GSM1276604PDAC Late Ablation 37.48
GSM1303940PDAC Late Ablation_anti-CTLA4 15.12
GSM1303941PDAC Late Ablation_anti-CTLA4 28.815
GSM1303942PDAC Late Ablation_anti-CTLA4 319.841